Table 1.
Overview of study features and admission characteristics of 1,094 participants
| |
|
Total |
Cohorted |
General bay |
|---|---|---|---|---|
| n = 1,094 | n = 211 | n = 883 | ||
| Age |
18 – 29 years |
298 (27.2%) |
53 (25.1%) |
245 (27.7%) |
| 30 – 39 years |
282 (25.8%) |
56 (26.5%) |
226 (25.6%) |
|
| 40 – 49 years |
193 (17.6%) |
40 (19.0%) |
153 (17.3%) |
|
| 50 – 59 years |
114 (10.4%) |
23 (10.9%) |
91 (10.3%) |
|
| 60 – 69 years |
110 (10.1%) |
25 (11.8%) |
85 (9.6%) |
|
| ≥ 70 years |
97 (8.9%) |
14 (6.6%) |
83 (9.4%) |
|
| Sex |
Female |
535 (48.9%) |
99 (46.9%) |
436 (49.4) |
| Male |
559 (51.1) |
112 (53.1%) |
447 (50.6%) |
|
| TB History |
No prior TB |
1,018 (93.1%) |
176 (83.4%) |
842 (95.4%) |
| First line only |
48(4.3%) |
23 (10.9%) |
25 (2.8%) |
|
| Second line |
28 (2.6%) |
12 (5.7%) |
16 (1.8%) |
|
| HIV |
Negative |
404 (36.9%) |
9 (4.3%) |
395 (44.7%) |
| Positive |
690 (63.1%) |
202 (5.7%) |
488 (55.3%) |
|
| CD4 count |
< 50 cells/mL |
58 (8.4%) |
20 (9.9%) |
38 (7.8%) |
| 50 – 99 cells/mL |
100 (14.5%) |
28 (13.9%) |
72 (14.8%) |
|
| 100 – 249 cells/mL |
170 (24.6%) |
51 (25.2%) |
119 (24.4%) |
|
| 250 – 349 cells/mL |
203 (29.4%) |
53 (26.2%) |
150 (30.7%) |
|
| 350 – 499 cells/mL |
73 (10.6%) |
22 (10.9%) |
51 (10.5%) |
|
| ≥ 500 |
86 (12.5%) |
28 (13.9%) |
58 (11.9%) |
|
| ART before admission |
217 (31.4%) |
54 (26.7%) |
163 (33.4%) |
|
| ART during admission | 255 (37%) | 78 (38.6%) | 177(6.2%) | |